Type 2 Diabetes and Cardiovascular Disease: Reducing the Risk

Journal of Managed Care Pharmacy
doi 10.18553/jmcp.2007.13.s2-a.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Academy of Managed Care Pharmacy

Related search

Type 2 Diabetes and Cardiovascular Risk Factors

Current Medical Research and Opinion
Medicine
2011English

Apolipoprotein E Gene Polymorphism and Risk of Type 2 Diabetes and Cardiovascular Disease

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2016English

Molecular Clocks, Type 2 Diabetes and Cardiovascular Disease

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2008English

Television Viewing and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality

JAMA - Journal of the American Medical Association
Medicine
2011English

Cardiovascular Risk in Patients With Type 2 Diabetes

CMAJ
Medicine
2005English

Postprandial Dysmetabolism and Cardiovascular Disease in Type 2 Diabetes

Postgraduate Medical Journal
Medicine
2005English

The CANVAS Program: Implications of Canagliflozin on Reducing Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Gallstone Disease and the Risk of Type 2 Diabetes

Scientific Reports
Multidisciplinary
2017English

Contribution of Non Traditional Cardiovascular Risk Factors to the Cardiovascular Disease in Patient With Type 2 Diabetes

Zagazig University Medical Journal
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy